BioEngLink
ActiveSummary
BioEngLink has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,000 and a net result of €17,434. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 11,726 sector peers (NACE 71, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
02-02
NBB filing
Annual accounts filed
financial year 2025 · micro format · 2 days late
2025
05-02
NBB filing
Annual accounts filed
financial year 2024 · micro format · 5 days late
2024
30-06
Financial
Highest result from 2021 to 2025net €18,991 ▲0.5%
Net result €18,991, the highest in the series.
31-01
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-01
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-01
NBB filing
Annual accounts filed
financial year 2021 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.